Nanobody and Its Therapeutic Applications

Nanobody and Its Therapeutic Applications

Background and purpose: Monoclonal antibodies market has grown since approval of Muromonab-CD3 (trade name Orthoclone OKT3) in 1986 as immuno- suppressor. Nevertheless, the undesirable effects of these large specific biomolecules calls for further attempts for more effective alternatives. Variable d...

Full description

Bibliographic Details
Main Author: Maryam Darvish
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2018-04-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
nanobody
vhh
phage display
monoclonal antibodies
Online Access:http://jmums.mazums.ac.ir/article-1-10331-en.html

Similar Items

Similar Items